In the News

Rapid Increase of a SARS-CoV-2 Variant With Multiple Spike Protein Mutations Observed in the United Kingdom

By Denise Baez

A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant has been identified in the United Kingdom, and preliminary analysis suggests that the variant is significantly more transmissible than previously circulating variants, according to a Threat...

FDA Issues Emergency Use Authorisation for Second COVID-19 Vaccine

The US Food and Drug Administration (FDA), on December 18, 2020, issued an emergency use authorisation (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The EUA allows Moderna’s...

ACAAI Updates Guidance Related to Risk of Allergic Reactions With mRNA COVID-19 Vaccines

The American College of Allergy, Asthma, and Immunology (ACAAI) has issued guidance for physicians and other providers related to the risk of an allergic reaction following vaccination with an mRNA-based coronavirus disease 2019 (COVID-19) vaccine.

ACAAI’s recommendations are in line with...

Early Tracheostomy Noninferior to Late Tracheostomy in Patients With COVID-19

By Denise Baez

Among patients with coronavirus disease 2019 (COVID-19) who were treated during the first 2 months of the pandemic in New York City, early tracheostomy was noninferior to late tracheostomy, and was associated with improvement in some outcomes, according to a study published...

Hyperglycaemia and Hypoglycaemia Associated With Poor Outcomes in Patients With COVID-19

By Denise Baez

NEW YORK -- December 17, 2020 -- Both hyperglycaemia and hypoglycaemia were associated with poor outcomes in patients with coronavirus disease 2019 (COVID-19), according to a study published in Diabetes Care.

An analysis of 1,544 patients with COVID-19 from 91...

FDA’s Vaccine Committee Votes in Favour of Issuing EUA for Moderna’s COVID-19 Vaccine

By Denise Baez

NEW YORK -- December 17, 2020 -- The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted in favour of issuing an Emergency Use Authorization (EUA) to Moderna’s mRNA-1273 coronavirus disease 2019 (COVID-19)...

FDA Issues EUA for First Fully At-Home OTC Diagnostic Test for COVID-19

The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for coronavirus disease 2019 (COVID-19).

The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test that detects fragments of...

FDA Issues Emergency Use Authorisation for First COVID-19 Vaccine

The US Food and Drug Administration (FDA) issued the first emergency use authorisation (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals aged 16 years and older.

The EUA...

Baricitinib Plus Remdesivir Reduces Recovery Time for Hospitalised Patients With COVID-19

By Denise Baez

Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients hospitalised with coronavirus disease 2019 (COVID-19), especially among ventilated patients, according to a study published...

FDA’s Vaccine Committee Votes in Favour of Issuing EUA for BNT162b2 COVID-19 Vaccine

By Denise Baez

NEW YORK -- December 10, 2020 -- The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted in favour of issuing an Emergency Use Authorization (EUA) to Pfizer’s BNT162b2 coronavirus disease 2019 (COVID-19)...